...Good morning everyone. Welcome to the 2025 Bicara Therapeutics Annual Meeting of Stockholders. My name is Claire Mazumdar, Chief Executive Officer of the company, and I will serve as the chair for today's meeting. The Annual Meeting of Stockholders is now called to order. I've asked Lara Meisner, our Chief Legal Officer and corporate secretary, to to record the minute. Before we proceed, I would like to let you know that members of our Board and our management team have joined us virtually. Also with us today are representatives from KPMG, the company's independent registered public accounting firm, and Goodwin Proctor, our outside counsel. Now let's proceed with the formal business of the meeting, notice of which was sent to all shareholders of record as the close of business on April 14, 2025. Please note that only shareholders of record on that date are entitled to vote at this meeting. The rules of conduct for this meeting are available in the files section in the lower right hand corner...
